3,4-methylenedioxyethamphetamine has been researched along with Encephalopathy, Toxic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gudelsky, GA; Johnson, BN; Weber, GF; Yamamoto, BK | 1 |
| Maldonado Adrian, C; McCann, UD; Mueller, M; Ricaurte, GA; Yuan, J | 1 |
2 other study(ies) available for 3,4-methylenedioxyethamphetamine and Encephalopathy, Toxic
| Article | Year |
|---|---|
Effects of stress and MDMA on hippocampal gene expression.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Gene Expression Regulation; Hippocampus; Neurotoxicity Syndromes; Protein Biosynthesis; Protein Folding; Rats; Serotonin; Serotonin Agents; Stress Disorders, Post-Traumatic | 2014 |
Inhibition of 3,4-methylenedioxymethamphetamine metabolism leads to marked decrease in 3,4-dihydroxymethamphetamine formation but no change in serotonin neurotoxicity: implications for mechanisms of neurotoxicity.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Deoxyepinephrine; Dextromethorphan; Excitatory Amino Acid Antagonists; Hydroxyindoleacetic Acid; Male; Neurotoxicity Syndromes; Neurotoxins; Rats; Rats, Sprague-Dawley; Serotonin; Sulfides | 2011 |